Showing results (21-30 of 225) with videos related to
Sort By:
Pageof 23
Psychological Medicine|February 24, 2001
What contributes to depression in Parkinson's disease?A Schrag, M Jahanshahi, N P QuinnMovement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
Reduction of Parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single-dose challengesA Schrag, L Schelosky, U Scholz, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2004
Reliability of self-reported diagnoses in patients with neurologically unexplained symptomsA Schrag, R J Brown, M R TrimbleTAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|December 1, 2018
Across-years prediction of hybrid performance in maize using genomicsTobias A Schrag, Wolfgang Schipprack, Albrecht E MelchingerNeurology|September 20, 2000
Low-dose olanzapine for levodopa induced dyskinesiasA J Manson, A Schrag, A J LeesTAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|September 5, 2012
Genetic diversity analysis of elite European maize (Zea mays L.) inbred lines using AFLP, SSR, and SNP markers reveals ascertainment bias for a subset of SNPsElisabetta Frascaroli, Tobias A Schrag, Albrecht E MelchingerLancet (London, England)|November 30, 1999
Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional studyA Schrag, Y Ben-Shlomo, N P QuinnJournal of Neurology, Neurosurgery, and Psychiatry|August 1, 1984
A double blind trial of sulpiride in Huntington's disease and tardive dyskinesiaN Quinn, C D MarsdenInternational Journal of Drug Discovery and Pharmacology|July 16, 2025
Hippo Signaling: Advances in Potential Therapeutic Targets for Sinoatrial Node DisordersJulianna N Quinn, Jun WangPageof 23